​

Funding Round

Seed Round - Phrontline Biopharma

Seed Round - Phrontline Biopharma

Investment Firm

Overview

Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.

Announced Date

Jun 27, 2024

Funding Type

Seed

Highlights

Location

Asia

Social

N/A

Investor Lead

Decheng Capital

Decheng Capital

Decheng Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

1

Investor Name
Participant InvestorDecheng Capital

Round Details and Background

Phrontline Biopharma raised $13758565 on 2024-06-27 in Seed Round

Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2024
Seed Round - Phrontline Biopharma
1-undefined
Jun 27, 2024
Seed Round - Phrontline Biopharma
1-13.8M

Recent Activity

There is no recent news or activity for this profile.